Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

Cited by (868)

Items 201–300 of 868

1. Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
   Chanchal Sharma, Sang Ryong Kim · 2021 · Antioxidants
2. Association of APOE with tau-tangle pathology with and without β-amyloid
   José M. Farfel, Lei Yu, Philip L. De Jager, Julie A. Schneider, David Alan Bennett · 2015 · Neurobiology of Aging
3. ApoE immunoreactivity and microglial cells in Alzheimer’s disease brain
   Uchihara, Toshiki, Duyckaerts, Charles, He, Yi, Kobayashi, Katsuji, Seilhean, Danielle, Amouyel, Philippe, Hauw, Jean-Jacques · 1995 · Neuroscience Letters
4. GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice
   Boyd, Tim D., Bennett, Steven P., Mori, Takashi, Governatori, Nicholas, Runfeldt, Melissa, Norden, Michelle, Padmanabhan, Jaya, Neame, Peter, Wefes, Inge, Sanchez-Ramos, Juan et al. · 2010 · Journal of Alzheimer's Disease
5. Genetics of Alzheimer’s Disease
   María Elisa Alonso Vilatela, Marisol López, Petra Yescas · 2012 · Archives of Medical Research
6. Potential implications of endogenous aldehydes in β‐amyloid misfolding, oligomerization and fibrillogenesis
   Chen, Kun, Maley, Jason, Yu, Peter H. · 2006 · Journal of Neurochemistry
7. Apolipoproteins and aging: emerging mechanisms
   Jonathan D. Smith · 2002 · Ageing Research Reviews
8. Anti-ApoE Antibody Given after Plaque Onset Decreases Aβ Accumulation and Improves Brain Function in a Mouse Model of Aβ Amyloidosis
   Liao, Fan, Hori, Yukiko, Hudry, Eloise, Bauer, Adam Q., Jiang, Hong, Mahan, Thomas E., Lefton, Katheryn B., Zhang, Tony J., Dearborn, Joshua T., Kim, Jungsu et al. · 2014 · The Journal of Neuroscience
9. APOE-amyloid interaction: Therapeutic targets
   Wisniewski, Thomas, Drummond, Eleanor · 2020 · Neurobiology of Disease
10. Neuroserpin: a serpin to think about
    Elena Miranda, David A. Lomas · 2006 · Cellular and Molecular Life Sciences
11. Cascading Glia Reactions: a Common Pathomechanism and Its Differentiated Control by Cyclic Nucleotide Signaling
    Peter Schubert, Tadao Morino, Hirofumi Miyazaki, Tadanori Ogata, Yoichi Nakamura, Cristina Marchini, Stefano Ferroni · 2000 · Annals of the New York Academy of Sciences
12. The human NACP/α-synuclein gene: chromosome assignment to 4q21.3–q22 and TaqI RFLP analysis
    Xiaohua Chen, H.A.Rohan de Silva, Mark J. Pettenati, P. Nagesh Rao, Peter St George‐Hyslop, Allen D. Roses, Yu Xia, Karen J. Horsburgh, Kenji Uéda, Tsunao Saitoh · 1995 · Genomics
13. ole of apoE/Aβ Interactions in the Pathogenesis of Alzheimer's Disease and Cerebral Amyloid Angiopathy
    Holtzman, David M. · 2001 · Journal of Molecular Neuroscience
14. Heat Shock Proteins and Amateur Chaperones in Amyloid-Beta Accumulation and Clearance in Alzheimer’s Disease
    Micha M.M. Wilhelmus, Robert M.W. de Waal, Marcel M. Verbeek · 2007 · Molecular Neurobiology
15. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons
    Jaya Padmanabhan, Monique M. Levy, Dennis W. Dickson, Huntington Potter · 2006 · Brain
16. The role of innate immunity in Alzheimer's disease
    Hannah E. Ennerfelt, John R. Lukens · 2020 · Immunological Reviews
17. Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease
    Gearing, Marla, Mori, Hiroshi, Mirra, Suzanne S. · 1996 · Annals of Neurology
18. Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
    Sala Frigerio, Carlo, De Strooper, Bart · 2016 · Annual Review of Neuroscience
19. Hypoxia, a Novel Inducer of Acute Phase Gene Expression in a Human Hepatoma Cell Line
    Roland H. Wenger, Andreas Rolfs, Hugo H. Marti, Christian Bauer, Max Gassmann · 1995 · Journal of Biological Chemistry
20. Genetic studies in Alzheimer's disease with an NACP/α‐synuclein polymorphism
    Yu Xia, H. A. Rohan de Silva, B.L. Rosi, Larry H. Yamaoka, Jacqueline B. Rimmler, Margaret Ann Pericak‐Vance, Allen D. Roses, Xiaohua Chen, Eliezer Masliah, Richard M. DeTeresa et al. · 1996 · Annals of Neurology
21. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length
    Patrick G. Kehoe, Michael Krawczak, Peter S. Harper, Michael John Owen, A. L. Jones · 1999 · Journal of Medical Genetics
22. A 2.6 å structure of a serpin polymer and implications for conformational disease 1 1Edited by R. Huber
    James A. Huntington, Navraj S Pannu, Bart Hazes, Randy J. Read, David A. Lomas, Robin W. Carrell · 1999 · Journal of Molecular Biology
23. The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis
    Claudio A. Soto, Eduardo Miguel Castaño · 1996 · Biochemical Journal
24. Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses
    LaDu, Mary Jo, Shah, Javeed Ali, Reardon, Catherine A, Getz, Godfrey S, Bu, Guojun, Hu, Jingru, Guo, Ling, Van Eldik, Linda J · 2001 · Neurochemistry International
25. Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
    Paul G. Ince, Elaine King Perry, Christopher M. Morris · 1998 · Brain Pathology
26. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis
    Kunal Dhiman, Kaj Blennow, Henrik Zetterberg, Ralph Nigel Martins, Veer Bala Gupta · 2019 · Cellular and Molecular Life Sciences
27. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry
    Aksam J. Merched, Jean‐Marie Sérot, Sophie Visvikis‐Siest, Dominique Aguillon, Gilbert Charles Faure, Gérard Siest · 1998 · FEBS Letters
28. ?-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma
    Joseph F. Poduslo, Geoffry L. Curran, Asok R. Kumar, Blas Frangione, Claudio A. Soto · 1999 · Journal of Neurobiology
29. Aβ40 is a major form of β-amyloid in nonhuman primates
    Marla Gearing, Johannes Tigges, Hiroshi Mori, Suzanne Samuels Mirra · 1996 · Neurobiology of Aging
30. Examining the zinc binding site of the amyloid‐β peptide
    Dun‐Sheng Yang, JoAnne McLaurin, Kefeng Qin, David A. Westaway, Paul E. Fraser · 2000 · European Journal of Biochemistry
31. Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: Antagonistic pleiotropy and premature brain aging
    Li-Hung Chang, M. Andres, J. Sadino, Caroline S. Jiang, Helenna Nakama, Eric N. Miller, Thomas Ernst · 2011 · NeuroImage
32. A critical analysis of the ‘amyloid cascade hypothesis’
    A. Armstrong, Richard · 2014 · Folia Neuropathologica
33. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils
    Hatters, Danny M., Zhong, Ning, Rutenber, Earl, Weisgraber, Karl H. · 2006 · Journal of Molecular Biology
34. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.
    Thomas Wısnıewskı, Adam A. Golabek, Elzbieta Kida, K. E. Wisniewski, Blas Frangione · 1995 · Europe PMC (PubMed Central)
35. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease
    Sandro Sorbi, Benedetta Nacmias, Paolo Forleo, Silvia Piacentini, Stefania Latorraca, Luigi A. Amaducci · 1995 · Annals of Neurology
36. APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
    Liu, Chia-Chen, Murray, Melissa E., Li, Xia, Zhao, Na, Wang, Na, Heckman, Michael G., Shue, Francis, Martens, Yuka, Li, Yonghe, Raulin, Ana-Caroline et al. · 2021 · Science Translational Medicine
37. Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease
    Natalia Mast, Aicha Saadane, Ana Carolina Valencia‐Olvera, James Constans, Erin Maxfield, Hiroyuki Arakawa, Young Li, Gary E. Landreth, Irina A. Pikuleva · 2017 · Neuropharmacology
38. Apolipoprotein E and Alzheimer disease
    Yadong Huang · 2006 · Neurology
39. APP Function and Lipids: A Bidirectional Link
    Grimm, Marcus O. W., Mett, Janine, Grimm, Heike S., Hartmann, Tobias · 2017 · Frontiers in Molecular Neuroscience
40. Genetic variation at a single locus and age of onset for Alzheimer's disease
    Michael William Lutz, Donna G. Crenshaw, Ann M. Saunders, Allen D. Roses · 2010 · Alzheimer s & Dementia
41. α1-antichymotrypsin
    Noor A Kalsheker · 1996 · The International Journal of Biochemistry & Cell Biology
42. Regulation of protein function by native metastability
    Cheolju Lee, Soon-Ho Park, Min-Youn Lee, Myeong‐Hee Yu · 2000 · Proceedings of the National Academy of Sciences
43. Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
    Anna Andrea Lauer, Heike Sabine Grimm, Birgit Apel, Nataliya Golobrodska, Lara Kruse, Elina Ratanski, Noemi Schulten, Laura Schwarze, Thomas Slawik, Saskia Sperlich et al. · 2022 · Biomolecules
44. Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures
    LaDu, Mary Jo, Shah, Javeed Ali, Reardon, Catherine A., Getz, Godfrey S., Bu, Guojun, Hu, Jingru, Guo, Ling, Van Eldik, Linda J. · 2000 · Journal of Biological Chemistry
45. Mechanisms of neuronal death in disease: defining the models and the players
    Elena M. Ribé, Esther Serrano‐Saiz, Nsikan Akpan, Carol M. Troy · 2008 · Biochemical Journal
46. Alzheimer's amyloid β interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids
    Alexei R. Koudinov, Temirbolat T. Berezov, Asok R. Kumar, Natalia V. Koudinova · 1998 · Clinica Chimica Acta
47. Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis
    Christian Hölscher · 1998 · Neurobiology of Disease
48. Quantitation of apoE Domains in Alzheimer Disease Brain Suggests a Role for apoE in Aß Aggregation
    Hyun Soon Cho, Bradley T. Hyman, Steven Mark Greenberg, George William Rebeck · 2001 · Journal of Neuropathology & Experimental Neurology
49. Role of the Low-density Lipoprotein Receptor–Related Protein in β-Amyloid Metabolism and Alzheimer Disease
    Bradley T. Hyman, Dudley K. Strickland, George William Rebeck · 2000 · Archives of Neurology
50. Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation
    Jingru Hu, Linda J. Van Eldik · 1999 · Brain Research
51. Transgenic mouse models of Alzheimer’s disease
    Janus, Christopher, Chishti, M.Azhar, Westaway, David · 2000 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
52. Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells
    Caruso, Alessandra, Motolese, Marta, Iacovelli, Luisa, Caraci, Filippo, Copani, Agata, Nicoletti, Ferdinando, Terstappen, Georg C., Gaviraghi, Giovanni, Caricasole, Andrea · 2006 · Journal of Neurochemistry
53. Immunotherapy for Alzheimer's disease
    Thomas Wısnıewskı, Fernando Goñi · 2014 · Biochemical Pharmacology
54. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease
    Evan Dorey, Nina Chang, Qing Yan Liu, Ze Yang, Wandong Zhang · 2014 · Neuroscience Bulletin
55. Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch type (HCHWA‐D): II ‐ A Review of Histopathological Aspects
    Marion L. C. Maat–Schieman, Sjoerd G. van Duinen, Marjolijn Bornebroek, Joost Haan, Raymund A.C. Roos · 1996 · Brain Pathology
56. Amyloid β binding proteins in vitro and in normal human cerebrospinal fluid
    Golabek, Adam, Marques, Marcos A., Lalowski, Maciej, Wisniewski, Thomas · 1995 · Neuroscience Letters
57. Binding and uptake of Aβ1‐42 by primary human astrocytes in vitro
    Nielsen, Henrietta M., Veerhuis, Robert, Holmqvist, Bo, Janciauskiene, Sabina · 2009 · Glia
58. Glutamine synthetase, hemoglobin α-chain, and macrophage migration inhibitory factor binding to amyloid β-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer’s disease brain by immunoprecipitation
    Rieko Oyama, Hirotaka Yamamoto, Koiti Titani · 2000 · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
59. Inflammation and Alzheimer's Disease: Relationships between Pathogenic Mechanisms and Clinical Expression
    Piet Eikelenboom, Annemieke J.M. Rozemüller, Freek L. Van Muiswinkel · 1998 · Experimental Neurology
60. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
    Mroczko, Barbara, Groblewska, Magdalena, Litman-Zawadzka, Ala, Kornhuber, Johannes, Lewczuk, Piotr · 2018 · International Journal of Molecular Sciences
61. Amyloid β-Protein (Aβ) 1–40 But Not Aβ1–42 Contributes to the Experimental Formation of Alzheimer Disease Amyloid Fibrils in Rat Brain
    Ryong‐Woon Shin, Koichi Ogino, Akira Kondo, Takaomi C. Saido, John Q. Trojanowski, Tetsuyuki Kitamoto, Jun Tateishi · 1997 · Journal of Neuroscience
62. Binding of Gelsolin, a Secretory Protein, to Amyloid β-Protein
    Ved P.S. Chauhan, Indrani Ray, Abha Chauhan, Henryk M. Wı́sniewski · 1999 · Biochemical and Biophysical Research Communications
63. Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E
    Narendra Nathoo · 2003 · Molecular Pathology
64. Hemoglobin promotes A? oligomer formation and localizes in neurons and amyloid deposits
    Chun-Ying Wu, P LIAO, Lu Yu, S WANG, S CHEN, Chun-Ying Wu, Yu‐Min Kuo · 2004 · Neurobiology of Disease
65. Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment
    Steven Trent DeKosky, Miloš D. Ikonomović, Xiaoyan Wang, Martin Rhys Farlow, Stephen R. Wisniewski, Oscar L. López, James T. Becker, Judith A. Saxton, William Edward Klunk, Robert A. Sweet et al. · 2002 · Annals of Neurology
66. Residues in the synuclein consensus motif of the α-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid βA4 peptide
    Poul Henning Jensen, Esben Skipper Sørensen, Torben E. Petersen, Jørgen Gliemann, Lone Kjær Rasmussen · 1995 · Biochemical Journal
67. Expression of APP in transgenic mice: a Comparison of neuron-specific promoters
    Kerstin Andrä, Dorothée Abramowski, Mairead Duke, A. Probst, K.-H. Wiederhold, Kurt Bürki, Michel Goedert, Bernd Sommer, Matthias Staufenbiel · 1996 · Neurobiology of Aging
68. Amyloid β‐Protein, APOE Genotype and Head Injury
    James A. R. Nicoll, G.W. Roberts, David Ian Graham · 1996 · Annals of the New York Academy of Sciences
69. Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
    C. Galdeano, Elisabet Viayna, Irene Sola, Xavier Formosa, P. Camps, A. Badía, M. Victòria Clos, J. Relat, M. Ratia, M. Bartolini et al. · 2012 · Journal of Medicinal Chemistry
70. Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease
    Leake, A, Morris, C.M, Whateley, J · 2000 · Neuroscience Letters
71. Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models
    Takashi Morihara, Bruce Teter, Fusheng Yang, Giselle P. Lim, Sally G. Boudinot, F. Douglas Boudinot, Sally Ann Frautschy, Greg M. Cole · 2005 · Neuropsychopharmacology
72. Gene therapy in Alzheimer’s disease – potential for disease modification
    Per Nilsson, Nobuhisa Iwata, Shin‐ichi Muramatsu, Lars O. Tjernberg, Bengt G. Winblad, Takaomi C. Saido · 2010 · Journal of Cellular and Molecular Medicine
73. Annexin 5 and apolipoprotein E2 protect against Alzheimer’s amyloid-β-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site
    George Lee, Harvey B. Pollard, Nelson J. Arispe · 2002 · Peptides
74. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APP V717F transgenic mice
    Irizarry, Michael C., Cheung, Bonnie S., Rebeck, G. William, Paul, Steven M., Bales, Kelly R., Hyman, B. T. · 2000 · Acta Neuropathologica
75. The Alzheimer’s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway
    Jendresen, Charlotte, Årskog, Vibeke, Daws, Michael R., Nilsson, Lars N. G. · 2017 · Journal of Neuroinflammation
76. Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
    Gaetano Calabrese, Cristen M. Molzahn, Thibault Mayor · 2022 · Journal of Biological Chemistry
77. AßT Amyloidogenesis: Unique, or Variation on a Systemic Theme
    Robert Kisilevsky, Paul E. Fraser, Merrill D. Benson · 1997 · Critical Reviews in Biochemistry and Molecular Biology
78. LRP and senile plaques in Alzheimer’s disease: colocalization with apolipoprotein E and with activated astrocytes
    Katrin Arélin, Ayae Kinoshita, Christa M. Whelan, Michael C. Irizarry, George William Rebeck, Dudley K. Strickland, Bradley T. Hyman · 2002 · Molecular Brain Research
79. Amyloid-β Immunotherapy for Alzheimers Disease
    Hongjun Fu, B. Liu, Jeffrey L. Frost, Cynthia Ann Lemere · 2010 · CNS & Neurological Disorders - Drug Targets
80. Unregulated inflammation shortens human functional longevity
    Staley A. Brod · 2000 · Inflammation Research
81. Association of human, rat, and rabbit apolipoprotein E with ?-amyloid
    Mary Jo LaDu, John R. Lukens, Catherine A. Reardon, Godfrey S. Getz · 1997 · Journal of Neuroscience Research
82. Opposite roles of apolipoprotein E in normal brains and in Alzheimer’s disease
    Claudio Russo, Giovanna Angelini, Debora Dapino, Alessandra Piccini, Giuseppe Piombo, Gennaro Schettini, Shu Chen, Jan K. Teller, D Zaccheo, Pierluigi L. Gambetti et al. · 1998 · Proceedings of the National Academy of Sciences
83. Age-related changes of Alzheimer’s disease-associated proteins in cynomolgus monkey brains
    Nobuyuki Kimura, Kentaro Tanemura, Shin-ichiro Nakamura, Akihiko Takashima, Fumiko Ono, Ippei Sakakibara, Yoshiyuki Ishii, Shigeru Kyuwa, Yasuhiro Yoshikawa · 2003 · Biochemical and Biophysical Research Communications
84. Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration
    Kuszczyk, Magdalena A., Sanchez, Sandrine, Pankiewicz, Joanna, Kim, Jungsu, Duszczyk, Malgorzata, Guridi, Maitea, Asuni, Ayodeji A., Sullivan, Patrick M., Holtzman, David M., Sadowski, Martin J. · 2013 · The American Journal of Pathology
85. Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3
    Rebeck, G. William, Kindy, Mark, LaDu, Mary Jo · 2002 · Journal of Alzheimer's Disease
86. The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide
    Kimberly Boland, María Isabel Behrens, Dennis W. Choi, Karen Manias, David H. Perlmutter · 1996 · Journal of Biological Chemistry
87. Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
    Anna Andrea Lauer, Heike S. Grimm, Birgit Apel, Nataliya Golobrodska, Lara Kruse, Elina Ratanski, Noemi Schulten, Laura Schwarze, Thomas Slawik, Saskia Sperlich et al. · 2022 · Publications of the UdS (Saarland University)
88. β‐Amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury
    Karen J. Horsburgh, G. M. Cole, F. Yang, Mary J. Savage, Barry Greenberg, Stephen M. Gentleman, David Ian Graham, James A. R. Nicoll · 2000 · Neuropathology and Applied Neurobiology
89. Risk Factors for Cerebral Amyloid Angiopathy in the Elderly
    Masahito Yamada · 2002 · Annals of the New York Academy of Sciences
90. Aβ1–40 but not Aβ1–42 levels in cortex correlate with apolipoprotein E ϵ4 allele dosage in sporadic Alzheimer's disease
    Ishii, Kazuhiro, Tamaoka, Akira, Mizusawa, Hidehiro, Shoji, Shin-ichi, Ohtake, Toshiyuki, Fraser, Peter E, Takahashi, Hitoshi, Tsuji, Shoji, Gearing, Marla, Mizutani, Toshio et al. · 1997 · Brain Research
91. Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility
    Jessie Theuns · 2000 · Human Molecular Genetics
92. Reactive astrocytes and α1-antichymotrypsin in Alzheimer's disease
    Carmela R. Abraham · 2001 · Neurobiology of Aging
93. Vascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆
    Jiong Shi, George L. Perry, Mark A. Smith, Robert Paul Friedland · 2000 · Neurobiology of Aging
94. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation
    Huntington Potter · 2001 · Neurobiology of Aging
95. Oligomerization and fibril assembly of the amyloid-β protein
    Alex E. Roher, Jerome Y. Baudry, Michael O. Chaney, Yu‐Min Kuo, W. Blaine Stine, Mark R. Emmerling · 2000 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
96. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation
    Lars N. G. Nilsson, Gary W. Arendash, Ralph E. Leighty, David A. Costa, Mark A Low, Marcos F Garcia, Jennifer R Cracciolo, Amyn M. Rojiani, Xin Wu, Kelly R. Bales et al. · 2004 · Neurobiology of Aging
97. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity
    Robin L. Cotter, W. J. Burke, Vince Salazar Thomas, JANE F. POTTER, Jialin Zheng, Howard Eliot Gendelman · 1999 · Journal of Leukocyte Biology
98. Free radical theory of aging: Alzheimer’s disease pathogenesis
    Denham Harman · 1995 · AGE
99. Plasma amyloid β protein is elevated in late-onset Alzheimer disease families
    Nilüfer Ertekin‐Taner, Linda H. Younkin, Debra Yager, Francine C. Parfitt, Matthew Baker, Sanjay Asthana, Melanie L. Hutton, Steven G. Younkin, Neill R. Graff‐Radford · 2007 · Neurology
100. β-Amyloid Plaques: Stages in Life History or Independent Origin?
     Richard A. Armstrong · 1998 · Dementia and Geriatric Cognitive Disorders